Speech-Language Pathologists in Ash Flat, AR Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Autumn Treasure Speaight, MCD, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Highway 62 412 Ste L, Ash Flat, AR 72513 Phone: 870-243-6292

Olivia Louise Taylor, MCD, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Nix Ridge Rd, Ash Flat, AR 72513 Phone: 870-994-3107

Mrs. Jill M Carithers, M.S.E. CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: Rr 1 Box 185, Ash Flat, AR 72513 Phone: 870-322-8452

Brittany Wells Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Nix Ridge Rd, Ash Flat, AR 72513 Phone: 870-994-3103    Fax: 870-994-3108

From The Beginning Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Nix Ridge Rd, Ash Flat, AR 72513 Phone: 870-994-3103

Hope Satterwhite Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Nix Rd, Ash Flat, AR 72513 Phone: 870-283-1322

News Archive

Scientists map DNA replication process at the most fundamental level

The proteins that drive DNA replication—the force behind cellular growth and reproduction—are some of the most complex machines on Earth.

Abortion does not increase woman's risk for depression

Having an abortion does not increase a woman's risk for depression, according to a new study of nearly 400,000 women published today in JAMA Psychiatry.

Study shows taste of alcoholic drink can elicit dopamine activity in brain's reward centers

The taste of beer, without any effect from alcohol itself, can trigger dopamine release in the brain, which is associated with drinking and other drugs of abuse, according to Indiana University School of Medicine researchers.

Amarantus to announce results from preclinical study of new protein therapy for TBI

Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).

Researchers identify clear role for tags in mediating genetic risk for rheumatoid arthritis

In one of the first genome-wide studies to hunt for both genes and their regulatory "tags" in patients suffering from a common disease, researchers have found a clear role for the tags in mediating genetic risk for rheumatoid arthritis (RA), an immune disorder that afflicts an estimated 1.5 million American adults.

Read more Medical News

› Verified 5 days ago